NR4A1 and breast carcinoma: In fact, TNBC patients who achieved a pCR were shown to have significantly improved recurrence free survival and breast cancer specific survival, while the impact of pCR on patient outcomes was much less pronounced in those with hormone receptor positive disease [49].